FedQuery

The Emmes Company, LLC

UEI NBQCBJ6FXBU4 · MD · SAM.gov record ↗

$129.6M
FY2025 obligations
76
Contract awards
Feb 26, 2015
First action
Jun 30, 2026
Latest action

Obligations by agency

  • Department Of Health And Human Services$129.6M

Obligations by NAICS

Monthly obligations

Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Jul 26

Contracts ending within 18 months (recompete watch)

  • 75N95022C00041 ↗$1.2M

    NINDS CENTER FOR CLINICAL TRIAL RESOURCES

    Ends
    Sep 28, 2026
    Started
    Sep 29, 2022
    Agency
    National Institutes Of Health
    NAICS
    541714
  • 75N93020C00002 ↗$4.8M

    DATA MANAGEMENT AND DATA WAREHOUSING

    Ends
    Oct 13, 2026
    Started
    Oct 14, 2019
    Agency
    National Institutes Of Health
    NAICS
    541511
  • 75N98022C00001 ↗$9.2M

    DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH.

    Ends
    Oct 30, 2026
    Started
    Oct 31, 2021
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N94025F00001 ↗$612K

    NICHD:R&D:DATA COORDINATING CENTER FOR THE FOLLOW-UP OF THE SECOND PHASE (COHORT 2) OF THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES OBSERVATIONAL STUDY:NON-SEVERABLE

    Ends
    Nov 29, 2026
    Started
    Aug 14, 2025
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N93019F00132 ↗$0

    CLINICAL MONITORING INITIATIVE (CMI) FOR VRC 316, 317, 320, 603

    Ends
    Dec 30, 2026
    Started
    Apr 29, 2019
    Agency
    National Institutes Of Health
    NAICS
    541711
  • 75N95022F00003 ↗$0

    OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTATION TRIAL (CTN-013). 09/28/2022 - 01/31/2027. DSC6. 75N95022F00003 (TO3).

    Ends
    Jan 30, 2027
    Started
    Sep 27, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95023F00005 ↗$0

    STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 01/31/2027. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).

    Ends
    Jan 30, 2027
    Started
    Sep 14, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N98026F00002 ↗$2.0M

    DSC MANAGEMENT AND SUPPORT. APRIL 29, 2026 THROUGH FEBRUARY 28, 2027. N01DA-22-2253. TASK ORDER NO. 75N98026F00002 (TO 28)

    Ends
    Feb 27, 2027
    Started
    Apr 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N92026F00001 ↗$49K

    CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS

    Ends
    Feb 27, 2027
    Started
    Feb 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541690
  • 75N92026F00002 ↗$191K

    CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS

    Ends
    Feb 27, 2027
    Started
    Feb 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541690

Largest awards

  • 75N93021C00012 ↗$53.0M

    SDCC

    Ends
    Feb 27, 2027
    Started
    Feb 28, 2021
    Agency
    National Institutes Of Health
    NAICS
    541713
  • 75N91021C00009 ↗$18.2M

    CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT

    Ends
    May 30, 2027
    Started
    May 31, 2021
    Agency
    National Institutes Of Health
    NAICS
    541611
  • HHSN275201700002C ↗$10.7M

    DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT

    Ends
    May 27, 2027
    Started
    Jul 27, 2017
    Agency
    National Institutes Of Health
    NAICS
    541711
  • 75N98022C00001 ↗$9.2M

    DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH.

    Ends
    Oct 30, 2026
    Started
    Oct 31, 2021
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N91024C00024 ↗$9.0M

    LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB)

    Ends
    Aug 30, 2026
    Started
    Aug 31, 2024
    Agency
    National Institutes Of Health
    NAICS
    541611
  • 75N98026F00001 ↗$4.8M

    TASK ORDER 6 FOR THE CTN CLINICAL RESEARCH COORDINATING CENTER (CCC) CONTRACT

    Ends
    Aug 13, 2029
    Started
    Aug 14, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N93020C00002 ↗$4.8M

    DATA MANAGEMENT AND DATA WAREHOUSING

    Ends
    Oct 13, 2026
    Started
    Oct 14, 2019
    Agency
    National Institutes Of Health
    NAICS
    541511
  • 75N95025F00001 ↗$4.7M

    TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29

    Ends
    Jul 14, 2026
    Started
    Jul 15, 2025
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95025F00001 ↗$2.3M

    DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25).

    Ends
    Feb 27, 2026
    Started
    Feb 28, 2025
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N98026F00002 ↗$2.0M

    DSC MANAGEMENT AND SUPPORT. APRIL 29, 2026 THROUGH FEBRUARY 28, 2027. N01DA-22-2253. TASK ORDER NO. 75N98026F00002 (TO 28)

    Ends
    Feb 27, 2027
    Started
    Apr 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95023C00013 ↗$2.0M

    DATA COORDINATING CENTER (DCC) TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) CLINICAL SITES FOR NIMH

    Ends
    Aug 5, 2026
    Started
    Aug 6, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95025F00002 ↗$1.7M

    TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29

    Ends
    Mar 30, 2028
    Started
    Jul 15, 2025
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95025F00002 ↗$1.4M

    DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26).

    Ends
    Feb 28, 2028
    Started
    May 20, 2025
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95022C00041 ↗$1.2M

    NINDS CENTER FOR CLINICAL TRIAL RESOURCES

    Ends
    Sep 28, 2026
    Started
    Sep 29, 2022
    Agency
    National Institutes Of Health
    NAICS
    541714
  • 75N95022F00004 ↗$676K

    KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 03/31/2027. DSC6. 75N95022F00004 (TO4).

    Ends
    Mar 30, 2027
    Started
    Sep 27, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N98026F00001 ↗$670K

    DSC MANAGEMENT AND SUPPORT. APRIL 15, 2026 THROUGH NOVEMBER 30, 2027 N01DA-22-2253, TASK ORDER NO. 75N98026F00001 (TO 29) "COLLABORATIVE CARE FOR POLYSUBSTANCE USE IN PRIMARY CARE SETTINGS (CO-CARE)"

    Ends
    Nov 29, 2027
    Started
    Apr 16, 2026
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95022F00002 ↗$668K

    INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2).

    Ends
    Sep 29, 2027
    Started
    Sep 27, 2022
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N94025F00001 ↗$612K

    NICHD:R&D:DATA COORDINATING CENTER FOR THE FOLLOW-UP OF THE SECOND PHASE (COHORT 2) OF THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES OBSERVATIONAL STUDY:NON-SEVERABLE

    Ends
    Nov 29, 2026
    Started
    Aug 14, 2025
    Agency
    National Institutes Of Health
    NAICS
    541715
  • HHSN26800003 ↗$562K

    THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC)

    Ends
    Dec 30, 2025
    Started
    Aug 29, 2016
    Agency
    National Institutes Of Health
    NAICS
    541712
  • 75N95023F00004 ↗$538K

    CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27.

    Ends
    Aug 26, 2027
    Started
    Aug 27, 2023
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N95024F00003 ↗$525K

    CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28

    Ends
    Apr 1, 2028
    Started
    Aug 14, 2024
    Agency
    National Institutes Of Health
    NAICS
    541715
  • 75N98022F00001 ↗$496K

    EMMES CORP:1108738 [22-001337]

    Ends
    Mar 23, 2025
    Started
    Mar 27, 2022
    Agency
    National Institutes Of Health
    NAICS
    541611
  • 75N98026F00001 ↗$402K

    CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS

    Ends
    Apr 29, 2027
    Started
    Apr 30, 2026
    Agency
    National Institutes Of Health
    NAICS
    541690
  • 75N92025F00004 ↗$361K

    CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS

    Ends
    Apr 29, 2026
    Started
    Apr 30, 2025
    Agency
    National Institutes Of Health
    NAICS
    541690
  • 75N95026F00001 ↗$345K

    DSC6 GENERAL MANAGEMENT AND SUPPORT. MARCH 1, 2026 TO APRIL 30, 2026. N01DA-22-2253. TASK ORDER NO. 75N95026F00001 (TO27). (EO) 14271: DAP-NCAP-00000077

    Ends
    Apr 29, 2026
    Started
    Feb 28, 2026
    Agency
    National Institutes Of Health
    NAICS
    541715